859 related articles for article (PubMed ID: 8564266)
1. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
2. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
[TBL] [Abstract][Full Text] [Related]
3. Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.
Jansen FP; Mochizuki T; Maeyama K; Leurs R; Timmerman H
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):60-7. PubMed ID: 10935534
[TBL] [Abstract][Full Text] [Related]
4. Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?
Schlicker E; Kathmann M; Bitschnau H; Marr I; Reidemeister S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):482-8. PubMed ID: 8740140
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.
Jansen FP; Wu TS; Voss HP; Steinbusch HW; Vollinga RC; Rademaker B; Bast A; Timmerman H
Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183
[TBL] [Abstract][Full Text] [Related]
6. Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.
Schlicker E; Kathmann M; Reidemeister S; Stark H; Schunack W
Br J Pharmacol; 1994 Aug; 112(4):1043-8. PubMed ID: 7952862
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist effects of histamine H3 receptor ligands on 5-HT3 receptor-mediated ion currents in NG108-15 cells.
Allen MC
Eur J Pharmacol; 1998 Nov; 361(2-3):261-8. PubMed ID: 9865516
[TBL] [Abstract][Full Text] [Related]
9. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus.
Alves-Rodrigues A; Timmerman H; Willems E; Lemstra S; Zuiderveld OP; Leurs R
Brain Res; 1998 Mar; 788(1-2):179-86. PubMed ID: 9555002
[TBL] [Abstract][Full Text] [Related]
11. Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.
Taylor SJ; Kilpatrick GJ
Br J Pharmacol; 1992 Mar; 105(3):667-74. PubMed ID: 1352720
[TBL] [Abstract][Full Text] [Related]
12. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
13. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic activity of Y-25130 on 5-HT3 receptors.
Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
[TBL] [Abstract][Full Text] [Related]
15. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
16. The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.
Lucchelli A; Santagostino-Barbone MG; Barbieri A; Candura SM; Tonini M
Br J Pharmacol; 1995 Mar; 114(5):1017-25. PubMed ID: 7780635
[TBL] [Abstract][Full Text] [Related]
17. Interaction of clozapine with the histamine H3 receptor in rat brain.
Rodrigues AA; Jansen FP; Leurs R; Timmerman H; Prell GD
Br J Pharmacol; 1995 Apr; 114(8):1523-4. PubMed ID: 7541279
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.
Barnes JC; Brown JD; Clarke NP; Clapham J; Evans DJ; O'Shaughnessy CT
Eur J Pharmacol; 1993 Nov; 250(1):147-52. PubMed ID: 8119312
[TBL] [Abstract][Full Text] [Related]
19. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
20. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
Ozaki A; Fujishima Y; Sukamoto T
Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
